Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Roth MKM Initiates Coverage On Geovax Labs with Buy Rating, Announces Price Target of $20

Author: Benzinga Newsdesk | July 16, 2024 05:27am
Roth MKM analyst Jonathan Aschoff initiates coverage on Geovax Labs (NASDAQ:GOVX) with a Buy rating and announces Price Target of $20.

Posted In: GOVX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist